Home
1 888 2 DONATE(1 888 236-6283)
CLINICSDONORSVOLUNTEERSHOSPITALSMEDIA ROOMABOUT USCAREERS
Find a Clinic:  search Search this site:  search
Book an appointment
Home > What Should I Know? > R&D
Facebook youTube Twitter flickr
Why Should I Donate?
Who Needs Blood?
Can I donate?
Basic Eligibility
Donor Questionnaire
Malaria policy
Donation Date Calculator
American Sign Language
MSM
What Can I Donate?
Types of Donations
Blood
Plasma & Platelets
Stem Cells
Financial Gifts
Blood for Research
How Can I Get Involved?
In My Community
Send an e-card
Public Involvement
Volunteers
Partners for Life
What's Your Type
Sign Up to Learn More
OneMatch
Young Blood For Life
Assignment Saving Lives
National Blood Donor Week
What Should I Know?
FAQs
Pandemic Preparedness
Safety and Testing
Research & Development
West Nile Virus (WNV)
Transfusion Related Acute Lung Injury (TRALI)
vCJD Travel Deferral
Blackboard
Forms
Become a Volunteer
New Donor Form
Change Your Address
Join OneMatch
Become a Partner for Life Organization
Become a Partner for Life Member
Join Ready, Set... Give!
Donor Experience Survey
Hospitals
Customer Service
Circular of Information
Customer Letters
Plasma Protein Products
TransfusionMedicine.ca
Hospital Customer Forms
Resource Library
OneMatch Documents
Adverse Events
Diagnostic Services
 

Biography – Craig Jenkins

Director - Product Quality Monitoring

Canadian Blood Services
1800 Alta Vista
Ottawa, ON K1G 4J5

Phone: 613-739-2427
E-mail: craig.jenkins@blood.ca

  • Product Quality Monitoring

The Quality Monitoring Program (QMP) is a natural extension of the activities of the Development Program of Research & Development (R&D). This program further integrates the R&D group into CBS activities; it enhances the problem solving skills of the organization and better aligns CBS with Industry Best Practices. The Quality Monitoring Program serves two main functions. The first is heightened surveillance of product function beyond the measurements of the current quality control standards. The second is to act as a centralized trouble shooting group for the organization. The program, operating closely with NetCAD can co-ordinate the interaction of R&D subject matter experts with 'Operations' and 'QA&RA' and other departments to ensure timely and accurate resolution to primarily manufacturing issues. The initiative endeavors to provide information necessary to set new standards for blood and blood components as well as to utilize opportunities for improvement, especially with respect to opportunities for efficiencies, to enhance manufacturing capabilities to produce the best possible blood products.

While all areas of the R&D program offers a potential source of scientific expertise, three specific sites have been selected on the basis of relationship to each of our three main manufactured blood components as the primary supporters of the quality monitoring program. Vancouver, Edmonton and Hamilton sites provide the primary expert knowledge and support in the areas of Platelets, Red Blood Cells and Plasma respectively.

As the Director of the Quality Monitoring Program I am responsible for the daily and strategic activities of the program. Additional to the above responsibilities there is also contact with international colleagues involved in the quality monitoring of blood products to ensure CBS stays abreast with industry best practices.

Selected Publications:

Levin E, Culibrk B, Gyongyossy-Issa MIC, Weiss S, Scammell K, LeFresne W, Jenkins C, Devine DV. Implementation of buffy coat platelet component production: Comparison to platelet-rich plasma platelet production. Transfusion 48: 2331-7 (2008)

Ramirez-Arcos S, Jenkins C, Dion J, Bernier F, Delage G, Goldman M. Canadian Experience with detection of bacterial contamination in apheresis platelets. Transfusion 2007; 47: 421-9.


Top of the page Privacy and Access to Information | Terms of Use | Copyright © 1998-2014 Canadian Blood Services. All rights reserved.